Literature DB >> 12544869

Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities.

Rui Pei1, Jar-How Lee, Neng-Jen Shih, Mike Chen, Paul I Terasaki.   

Abstract

BACKGROUND: It is difficult to assign antibody specificity for highly sensitized patients using a cell panel with multiple antigens per reaction. We describe here a single antigen bead panel for accurate identification of human leukocyte antigen (HLA) antibody specificities by flow cytometry.
METHODS: A total of 110 single recombinant HLAs, including 34 A locus alleles, 57 B locus alleles, and 19 C locus alleles, were produced by a mammalian expression system. These single antigens were coated onto eight different colored microbeads, which were mixed together in one tube for simultaneous detection of HLA antibodies against eight different antigens per flow cytometry test.
RESULTS: Single HLA reacted specifically with the serologically defined monoclonal antibodies. The single antigen panel provided higher resolution than the regular cell panel for antibody detection by uncovering the masked specificities. Single antigens also provided higher sensitivity than the multiple antigens coated onto beads for HLA antibody detection as demonstrated by serum dilution studies. In 10 sera from patients who had rejected a kidney transplant, single antigen beads identified antibodies to 31 of 35 antigens that were mismatched in the donor. Most important, none of the reactions were against antigens present in the recipient.
CONCLUSION: An accurate and sensitive HLA antibody detection method is described using flow cytometry beads coated with single HLAs produced by recombinant technology. The single antigen beads should be useful in predicting negative crossmatch in highly sensitized organ recipients and highly sensitized patients requiring platelets.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12544869     DOI: 10.1097/00007890-200301150-00008

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  79 in total

1.  Mutation at positively selected positions in the binding site for HLA-C shows that KIR2DL1 is a more refined but less adaptable NK cell receptor than KIR2DL3.

Authors:  Hugo G Hilton; Luca Vago; Anastazia M Older Aguilar; Achim K Moesta; Thorsten Graef; Laurent Abi-Rached; Paul J Norman; Lisbeth A Guethlein; Katharina Fleischhauer; Peter Parham
Journal:  J Immunol       Date:  2012-07-06       Impact factor: 5.422

Review 2.  Acute rejection.

Authors:  Mark Benzimra; Greg L Calligaro; Allan R Glanville
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895

Review 3.  Soluble HLA: patterns of expression in normal subjects, autoimmune diseases, and transplant recipients.

Authors:  Irena Adamashvili; Roger E Kelley; Thomas Pressly; John C McDonald
Journal:  Rheumatol Int       Date:  2005-06-29       Impact factor: 2.631

Review 4.  Leukocyte antigen and antibody detection assays: tools for assessing and preventing pulmonary transfusion reactions.

Authors:  David F Stroncek; Emmanuel Fadeyi; Sharon Adams
Journal:  Transfus Med Rev       Date:  2007-10

Review 5.  Effector mechanisms of rejection.

Authors:  Aurélie Moreau; Emilie Varey; Ignacio Anegon; Maria-Cristina Cuturi
Journal:  Cold Spring Harb Perspect Med       Date:  2013-11-01       Impact factor: 6.915

Review 6.  Haploidentical hematopoietic transplantation without T-cell depletion: current status and future perspectives.

Authors:  Lei Gao; Xi Zhang
Journal:  Stem Cell Investig       Date:  2015-10-20

7.  Analysis of a high-throughput HLA antibody screening assay for use with platelet donors.

Authors:  Emmanuel Fadeyi; Sharon Adams; Brett Peterson; Julia Hackett; Phyllis Byrne; Harvey G Klein; Francesco M Marincola; Susan F Leitman; David F Stroncek
Journal:  Transfusion       Date:  2008-04-15       Impact factor: 3.157

8.  Perception versus reality?: Virtual crossmatch--how to overcome some of the technical and logistic limitations.

Authors:  A R Tambur; D S Ramon; D B Kaufman; J Friedewald; X Luo; B Ho; A Skaro; J Caicedo; D Ladner; T Baker; J Fryer; L Gallon; J Miller; M M Abecassis; J Leventhal
Journal:  Am J Transplant       Date:  2009-06-26       Impact factor: 8.086

9.  Retransplant candidates have donor-specific antibodies that react with structurally defined HLA-DR,DQ,DP epitopes.

Authors:  Rene J Duquesnoy; Yehia Awadalla; Jon Lomago; Larry Jelinek; Judy Howe; Dwayne Zern; Betty Hunter; Joan Martell; Alin Girnita; Adriana Zeevi
Journal:  Transpl Immunol       Date:  2007-10-30       Impact factor: 1.708

10.  Acute non-hemolytic transfusion reactions and HLA class I antibody: advantages of solid phase assay compared with conventional complement-dependent assay.

Authors:  S Imoto; K Kawamura; Y Tokumine; N Araki; S Akita; C Nishimura; H Inaba; K Saigo; O Mabuchi; H Okazaki
Journal:  Transfus Med       Date:  2009-10-30       Impact factor: 2.019

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.